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Prenatal screening of pregnant women for HIV is central to eliminating mother-to-child-
transmission (MTCT) of HIV. While some countries in sub-Saharan Africa (SSA) have
scaled up their prevention of MTCT programmes, ensuring a near-universal prenatal care
HIV testing, and recording a significant reduction in new infection among children, several
others have poor outcomes due to inadequate testing. We conducted a multi-country analy-
sis of demographic and health surveys (DHS) to assess the coverage of HIV testing during
pregnancy and also examine the factors associated with uptake.
Methods
We analysed data of 64,933 women from 16 SSA countries with recent DHS datasets
(2015–2018) using Stata version 16. Adjusted and unadjusted logistic regression models
were used to examine correlates of prenatal care uptake of HIV testing. Statistical signifi-
cance was set at p<0.05.
Results
Progress in scaling up of prenatal care HIV testing was uneven across SSA, with only 6.1%
of pregnant women tested in Chad compared to 98.1% in Rwanda. While inequality in
access to HIV testing among pregnant women is pervasive in most SSA countries and par-
ticularly in West and Central Africa sub-regions, a few countries, including Rwanda, South
Africa, Zimbabwe, Malawi and Zambia have managed to eliminate wealth and rural-urban
inequalities in access to prenatal care HIV testing.
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Conclusion
Our findings highlight the between countries and sub-regional disparities in prenatal care
uptake of HIV testing in SSA. Even though no country has universal coverage of prenatal
care HIV testing, East and Southern African regions have made remarkable progress
towards ensuring no pregnant woman is left untested. However, the West and Central Africa
regions had low coverage of prenatal care testing, with the rich and well educated having
better access to testing, while the poor rarely tested. Addressing the inequitable access and
coverage of HIV testing among pregnant women is vital in these sub-regions.
Introduction
With the introduction of antiretroviral treatments (ART), there has been a 40% decline in new
HIV infections from 2.9 million in 1997 to 1.7 million in 2019 [1]. Also, new infections have
declined by 52% among children from 310 000 in 2010 to 150 000 in 2019 [1]. However, with
over 150,000 new infections among children in 2018, mother to child transmission of HIV
(MTCT) remains a major public health concern [1]. What is more, 61% of global new infec-
tions among children in 2019 occurred among children in sub-Saharan Africa (SSA), with
western and central African countries having the highest record of children infected [1]. Suc-
cess in eliminating MTCT is vastly uneven in SSA. While Southern and Eastern African coun-
tries such as Comoros, Malawi, Rwanda, South Africa, Burundi, and Uganda have seen a
remarkable decline in MTCT transmission of HIV, many countries in West and Central Africa
like Angola, Equatorial Guinea, the Gambia, Mali, and Niger have experienced an increase in
transmission rate [2]. The intensification of the existing PMTCT program and scaling up of a
nationwide program to accelerate MTCT elimination in Malawi, Zimbabwe, and South Africa
have resulted in MTCT at 6-12weeks postpartum rate comparable to the ‘global north’ [3–7].
HIV testing before and during pregnancy is critical to initiating ART and eliminating
MTCT of HIV [8, 9]. The risk of MTCT of HIV ranges from 15–45%, without ART but could
be reduced to< 5% with prenatal care testing and initiation of ART [10]. Global north coun-
tries with a universal prenatal care HIV screening among pregnant women have nearly elimi-
nated MTCT of HIV [11–14]. However, SSA countries, particularly West and Central African
countries, still have a low prevalence of prenatal care HIV testing among pregnant women.
The high rate of MTCT of HIV in SSA reflects gaps in the PMTCT programmes in SSA, partic-
ularly in screening and diagnoses of pregnant women. It is, however, worth noting that the
health system’s response and dynamics of PMTCT implementation in SSA are markedly dif-
ferent from country to country. For instance, in Rwanda and Uganda, it is mandatory for
every pregnant mother who attends antenatal care (ANC) to test for HIV, rather than a volun-
tary choice of the mother [15, 16]. In South Africa and Botswana and like most SSA countries,
the opt-out policy was implemented and pregnant women are educated about HIV. However,
despite the acceptability and implementation of the opt out strategy [17], there is evidence a
large proportion of women who received ANC are not tested for HIV in some SSA countries
[2, 18].
Attendance of ANC is generally high in East and Southern African countries relative to
West and Central Africa countries, thus explaining the contrasting successes recorded in
PMTCT across SSA [19]. Even though HIV testing is generally available in all West African
countries, the challenge remains to ensure women access prenatal care and also ensure all
women who do are tested as part of prenatal care. In Nigeria, for example, about 30% of
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women who received prenatal care were not tested for HIV [2]. As such, significant gaps
remain in terms of universal testing of women who present for antenatal care. Nevertheless,
the larger percentage of unreached women remains those who never received prenatal care.
Some of the reasons why pregnant women do not test for HIV in SSA include inaccessibility
of healthcare facility [20], perceived lack of confidentiality, stigma, and discrimination [21,
22], cost, illiteracy, and inability to secure husband’s permission, attitude, and skills of health
workers and inadequate resources [23, 24]. Health behavioural theories such as the Health
belief model (HBM) [25] and Capability, Opportunity, and Motivation Model of Behaviour
(COM-B) model [26] have also highlighted barriers and enablers of uptake of health behav-
iours and behavioural change among individuals, including deciding to test for HIV during
pregnancy. Most of these theories and models explain or predict how internal and external fac-
tors influence an individual’s health behaviour. The Health Belief Model (HBM) could provide
an understanding of the relationship between individual factors such as knowledge of MTCT
and prenatal care uptake of HIV testing. Based on the proposition of HBM, mothers who have
good knowledge of MTCT can assess their susceptibility correctly, understand the severity of
MTCT of HIV, and the benefit of testing [27–29]. Lack of knowledge of MTCT could consti-
tute a significant barrier to the uptake of HIV testing, as mothers may not see the need for test-
ing or inaccurately assess their risk. According to the COM-B model, behaviour is a product of
three necessary conditions; capability, opportunity, and motivation. Capability can be psycho-
logical (knowledge) or physical (skills), opportunity can be social (societal influences) or physi-
cal (environmental resources) while motivation can be automatic (emotion) or reflective
(beliefs, intentions). COM-B model provides a comprehensive analysis of all factors influenc-
ing prenatal HIV testing [26].
Given the lack of recent data on prenatal testing in SSA and drawing from the COM-B
model and HBM theoretical propositions, we examined factors associated with uptake of HIV
testing during pregnancy in 16 sub-Saharan African countries. These countries are representa-
tive of all the sub-regions of SSA. Our study aligns with the global effort to achieve the
UNAIDS first 95% by 2030. The findings of the study will be useful for scaling up HIV testing
in SSA. It will facilitate cross-country comparison and could be used to support advocacy. In
the present study, we first estimated the prevalence of HIV testing during pregnancy in SSA
and the 16 countries included in our analysis. We then assessed the effects of knowledge of
MTCT, relevant individual and community level factors on HIV testing in these countries.
Methods
This cross-sectional study used recent Demographic and Health Surveys (DHS) data (2015–2018)
to examine MTCT knowledge and uptake of HIV testing during pregnancy in SSA. DHS is a
nationally representative survey collected every five years across low- and middle-income coun-
tries. We focused on 16 countries with recent DHS to assess the landscape of HIV testing during
pregnancy in SSA. Countries were included in the study if they had complete information on
HIV testing during pregnancy, MTCT knowledge, and have recent DHS (2015–2018) (see Fig 1).
The countries included were Benin, Guinea, Mali and Senegal from West Africa, Angola, Camer-
oon and Chad from Central Africa, Burundi, Ethiopia, Rwanda and Uganda from East Africa and
Malawi, Mozambique, South Africa, Zambia and Zimbabwe from Southern Africa.
The study population was women aged 15 to 49 who gave birth within two years preceding
the surveys. Weightings were applied to obtain unbiased estimates, according to the DHS
guidelines. Not using weights can bias results toward the oversampled sub-populations. The
study sample was, thus, a weighted sample of 65,107 women (Table 1). Details on the sampling
methodology and data collection used by the DHS are published elsewhere [30].
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Fig 1. Overview of country selection.
https://doi.org/10.1371/journal.pone.0242001.g001
Table 1. Sampling distribution and countries.
Countries and sub-region Data Collection Year Unweighted observations remaining Weighted observations remaining
Central Africa
Angola 2016 5,631 5,220
Cameroon 2018 3,575 3,692
Chad 2015 6,283 6,439
West Africa
Benin 2018 5,242 5,258
Guinea 2018 3,131 3,090
Mali 2018 3,875 4,090
Senegal 2017 4,251 3,906
East Africa
Burundi 2017 5,006 5,157
Ethiopia 2016 3,810 3,993
Rwanda 2016 3,103 3,167
Uganda 2016 5,645 5,535
Southern Africa
Malawi 2016 6,159 6,148
Mozambique 2015 2,044 2,223
South Africa 2016 1,301 1,308
Zambia 2018 3,699 3,623
Zimbabwe 2015 2,178 2,258
Total 64,933 65,107
https://doi.org/10.1371/journal.pone.0242001.t001
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Variables and measurement
Outcome of interest. The outcome variable of this study was HIV testing during preg-
nancy. Participants were asked if they tested for HIV as part of antenatal care and responses
were dichotomous (“Yes” or “No”).
Explanatory variables. Using the COM-B Model and HBM, we included both internal
and external factors in our analysis. The COM-B model and HBM propose that knowledge
and capability are important prerequisites for HIV testing. Capability can be psychological
(knowledge) or physical (skills). Knowledge of the benefit of testing and the severity of not test-
ing could influence women to test for HIV or not. As such, we included knowledge of MTCT
in our analysis. Three main questions on the transmission of HIV from mother to child during
pregnancy, delivery and breastfeeding were used to assess MTCT knowledge. Each respondent
was given a score of 1 for each correct answer. The available scores ranged from 0–3. We cate-
gorised a score of “0” as low, a score of “1–2” as moderate, and a score of “3” as high. Also,
according to COM-B model, opportunity and motivation are critical in factors that influence
the uptake of HIV testing. Education, marital status and wealth status would not only influence
an individual’s capability to navigate and overcome the barriers to testing for HIV during
pregnancy but also provide opportunity to access antenatal care and get tested. Age was cate-
gorised as “15–19 years”, “20–24 years”, ‘‘25–34 years” and “35–49 years”. Marital status was
classified as “Never married”, “Currently married”, “Previously married” and “Cohabiting”.
Education was measured by asking participants to report their highest level of education.
Their responses were classified as “No formal education”, “Primary education” and “Second-
ary and Higher education”. Wealth status was assessed as an index that combines household
assets and utilities. The index was then categorised as “Poor”, “Middle” and “Rich”. Also, we
included health insurance coverage, which is a binary choice variable of Yes or No. All coun-
tries in the study sample had responses except for Senegal and Rwanda. The COM-B model
emphasises the role of environmental factors in access and uptake of HIV testing. Where
women live is an important factor that could determine if HIV testing is available and accessi-
ble. Health resources are unevenly distributed, and women in rural areas are disadvantaged in
terms of access to health facilities that provide quality health care services. As such, we
included residential area, which is divided into “Rural” and “Urban”. Also, we included geopo-
litical zones, classified based on each country’s setting.
According to the COM-B model, motivation is an important predictor of uptake of HIV
testing. Even though the DHS did not directly measure women’s motivation, other factors
could influence one’s motivation. We believe exposure to media programme on the impor-
tance of HIV testing could not only educate women on the need to test but only motivate them
to test. Media exposure was constructed from three variables on the frequency of exposure to
three different media outlets, which are print media, radio, and television using principal com-
ponent analysis. The respondents were assigned 0 for “not at all”, 1 for “less than once a week”
and 2 for “at least once a week”. These were added up across all respondents with overall scores
of 0 to 6. We classified a score of “0”as "Low media exposure",”1 to 3” as "Moderate media
exposure", and 4 or greater as “High media exposure". This classification was applicable to all
countries except Zambia. For Zambia, there was an additional category–“almost every day”–
which we coded as 3. The available score for Zambia is 0 to 9. We classified “0” as "Low media
exposure", “1 to 3” as "Moderate media exposure", and 4 or greater as “High media exposure".
We included countries as a variable to account for variation in the implementation of the
“Opt-out” policy and the use of antenatal care services across the region. The “Opt-out” policy
and rate of antenatal service utilisation are important factors influencing uptake of HIV testing
during pregnancy. However, all women that did not receive antenatal care services also did
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not test for HIV. As such, we are unable to include antenatal care attendance in our regression
model. However, countries become an important proxy to account for the role of the disparate
rate of antenatal care attendance across SSA counties. Also, the extent of implementation of
the “Opt-out” policy, which is widely accepted and is implemented in SSA, varies. Therefore,
countries become an important variable to account for these variations.
Statistical analyses
The analyses were carried out using STATA Version 16.0. The analysis began by computing
descriptive statistics, such as frequencies and percentages for the main explanatory variable
and the outcome variable. We also performed Pearson’s chi-square test analysis to examine the
relationship between knowledge of MTCT and uptake of testing. We pooled the dataset of all
countries to create a single dataset, yielding a total weighted sample of 65,106. Multivariable
logistic regression models were used to examine factors associated with uptake of HIV testing
during pregnancy in SSA. We stratified the regression analysis by countries to show the factors
associated with prenatal testing in each country included. The results of the regression analyses
were presented as odds ratios (OR), with their corresponding 95% confidence intervals (CI)
signifying significance and precision of the reported OR.
Ethical considerations
The DHS surveys are conducted after approval of ethical review bodies and authorisation by
the country of the study. De-identified datasets are freely available on the DHS website
(https://dhsprogram.com/data/available-datasets.cfm). Since this is a secondary analysis, we




We presented the prevalence of uptake of HIV testing during pregnancy in each of the 16 SSA
countries included in the study in Fig 2. We found that the uptake of HIV testing ranges from
about 6.1% in Chad to about 98.1% in Rwanda. We observed that the uptake of HIV testing
was highest among women in Southern and Eastern African countries, whereas the uptake of
HIV testing was lowest among women in Western and Central Africa countries (Fig 2).
Table 2A and 2B report the proportion of women who had HIV testing during pregnancy
by background characteristics across the 16 SSA countries. Prevalence of prenatal HIV testing
was higher among women older than 19 compared to women aged 19 or below in all countries
except in Mozambique, South Africa and Zimbabwe. The proportion of never-married
women who tested for HIV during pregnancy were higher compared to married women in
Angola, Cameroon, Chad, Benin, Guinea, Mali, Ethiopia, Mozambique, Zambia and Zimba-
bwe. Also, the prevalence of HIV testing was highest among women who owned health insur-
ance, resided in urban areas, had a high media exposure, belonged to rich wealth quintile and
had secondary or higher level of education in all SSA countries studies. In all countries, uptake
of HIV testing during pregnancy was significantly higher among women with moderate to
high knowledge of MTCT than among those with low knowledge of MTCT. Even countries
where uptake of HIV testing during pregnancy was high, women who had a high knowledge
of MTCT were more likely to test for HIV compared to women who had low knowledge of
MTCT (Rwanda 98.1% vs 87.1%, Malawi 91.7% vs 63.5%, South Africa 92.5% vs 60.9%,
Uganda 92.4% vs 72.1%, Zambia 96.9% vs 54.9%, Zimbabwe 92.7% vs 46.6%).
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Multivariable findings
We fitted two models to examine the factors associated with uptake of HIV testing during
pregnancy. Model 1 was an unadjusted model with no covariates. Women aged 20–49 had a
higher likelihood of prenatal uptake of HIV testing than women aged 15–19 years. Married
women had lower odds of prenatal HIV testing relative to never-married women. Secondary
education or higher, high wealth status, and high media exposure were associated with a higher
likelihood of prenatal HIV testing. Ownership of health insurance was associated with higher
odds of prenatal testing. In all countries, women who had moderate to high knowledge of
MTCT had higher odds of HIV testing uptake during pregnancy compared with women who
had low MTCT knowledge (Table 3).
Model 2 is the adjusted model where we included sociodemographic factors, media expo-
sure, and health insurance as covariates. After controlling for countries in the adjusted model,
women were more likely to test for HIV as part of antenatal care if they had a high knowledge
of MTCT (AOR: 7.08; 95% CI: 6.66, 7.53), aged 35–49 (AOR: 1.33; 95% CI: 1.21, 1.46), had a
secondary or higher level of education (AOR:2.57; 95% CI: 2.38, 2.77), belong to rich wealth
quintile(AOR: 1.83; 95% CI: 1.70, 1.97), resided in the urban area (AOR: 1.68; 95% CI: 1.58,
1.80), exposed to the media (AOR: 1.77; 95% CI: 1.62, 1.94), and owned a health insurance
cover (AOR: 1.41; 95% CI: 1.21, 1.64). We did not include ANC in the model, given that the
prevalence of HIV testing uptake was 0% among women who did not receive ANC. However,
we presented the result of testing prevalence and ANC attendance for all countries included,
Fig 2. Uptake of HIV testing during pregnancy across SSA countries.
https://doi.org/10.1371/journal.pone.0242001.g002
PLOS ONE Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa
PLOS ONE | https://doi.org/10.1371/journal.pone.0242001 November 9, 2020 7 / 15
Table 2. Relationship between background factors and prenatal care uptake of HIV testing stratified by country.
(A)
SSA Central Africa West Africa
Variables Angola Cameroon Chad Benin Guinea Mali Senegal
Age group in years
15–19 56.2 48.4 72.5 5.4 16.3 23.6 16.6 50.1
20–24 62.7 53.5 78.0 5.7 19.8 24.1 20.4 62.9
25–34 59.9 54.0 75.8 6.4 21.1 23.2 21.0 66.9
35–49 58.3 47.0 71.6 6.5 23.2 18.8 19.7 68.3
Marital Status
Never Married 75.3 54.8 87.6 11.4 30.5 34.0 23.7 62.7
Currently Married 54.9 42.7 70.5 5.7 19.2 21.6 20.0 64.8
Previously 70.4 52.1 73.3 8.3 18.2 39.3 19.8 64.5
Cohabiting 69.2 53.0 83.5 7.7 25.0 25.7 16.4 92.5
Education level
None 34.2 22.8 47.7 3.7 16.2 16.9 13.2 58.7
Primary 72.1 46.7 74.6 8.1 25.0 28.1 23.4 71.3
Sec. & Higher 81 82.7 93.2 14.1 31.7 48.1 46.5 77.4
Wealth Status
Poor 52.4 21.6 59.5 4.4 13.9 11.7 8.1 51.7
Middle 59.5 62.3 81.6 4.2 19.9 17.6 11.1 68.7
Richest 69.9 87.3 93.5 9.1 28.6 40.4 39.0 82.4
Residential Areas
Rural 56 21.4 65.2 4.3 17.2 14.0 13.0 56.9
Urban 70.2 72.1 88.7 13.7 26.4 44.2 46.8 79.9
Media Exposure
Low 48 23.0 58.5 4.1 14.4 12.7 8.5 41.3
Moderate 65.2 58.6 87.0 9.5 22.1 23.5 16.9 61.4
High 75.7 84.6 95.5 17.6 34.7 44.8 35.3 75.7
Health Insurance Cover
No 59 51.3 74.9 5.9 20.5 22.1 18.1
Yes 85.7 66.7 96.6 90.6 50.3 71.4 63.1
Know MTCT
Low 15.1 12.6 41.5 0.8 3.0 8.8 10.7 56.8
Moderate 74.5 61.3 74.8 20.4 52.7 27.9 31.2 66.7
High 76 74.8 81.2 26.3 49.3 32.1 23.1 68.5
(B)
East Africa Southern Africa
Variables Burundi Ethiopia Rwanda Uganda Malawi Mozambique South Africa Zambia Zimbabwe
Age group in years
15–19 84.9 31.2 98.7 89.8 83.0 75.3 94.0 90.8 91.8
20–24 91.7 37.8 98.5 93.3 91.0 74.2 89.2 94.9 91.1
25–34 91.4 36.3 98.1 93.4 90.8 71.3 88.6 93.8 89.1
35–49 90.1 30.4 97.5 89.4 87.9 65.6 89.8 94.4 88.3
Marital Status
Never Married 87.7 50.5 97.8 91.0 79.2 80.0 89.8 95.2 94.6
Currently Married 92.3 35.3 98.9 92.5 90.4 67.0 90.3 93.7 89.5
Previously 90.7 27.7 95.7 91.7 86.3 66.6 97.4 91.0 89.3
(Continued)
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and the results show that testing the proportion of women who tested during pregnancy was
higher in countries with HIV coverage of ANC than in those with low coverage.
We stratified the results by country to report on the homogeneity and heterogeneity of the
results. The findings are shown in S1–S6 Tables. In both the adjusted and unadjusted models,
the odds of uptake of HIV testing as part of antenatal care was higher among women with high
MTCT knowledge in all countries studied.
Older age (aged 20 to 49) was significantly associated with a higher likelihood of uptake of
HIV testing during pregnancy only in Angola, Benin, Mali, Senegal, and Burundi. There was
heterogeneity in the result of the association between marital status and uptake of HIV testing.
In most countries, marital status was not significantly related to prenatal uptake of testing.
Married women had higher odds of uptake of HIV testing in Burundi compared to never-mar-
ried women. However, the contrast was found in Zimbabwe, where married women were 63%
less likely to test during antenatal care. In all countries studied, except Malawi and South
Africa, women who had a secondary or higher level of education were more likely to test for
HIV as part of ANC compared to women who had no formal education. Rich wealth status
was significantly associated with higher odds of uptake of HIV testing in all countries, except
Malawi, Zimbabwe, Zambia, South Africa, Uganda, Rwanda, and Chad.
Similarly, urban-dwelling was associated with a higher likelihood of HIV testing uptake in
all countries, except in Zambia, Zimbabwe, South Africa, Uganda and Rwanda. Surprisingly,
women were significantly less likely to test for HIV during ANC if they reside in urban areas
in South Africa. High media exposure was associated with a higher odd of prenatal care uptake
of HIV testing in all countries studied, except in Rwanda, Uganda, and South Africa. Lastly,
ownership of health insurance was significantly associated with uptake of HIV testing as part
Cohabiting 87.8 39.1 97.5 92.5 88.7 79.1 86.0 97.4 93.1
Education level
None 89.7 24.0 95.4 88.3 86.3 58.3 93.6 80.5 87.3
Primary 91.4 43.5 98.4 90.4 88.6 73.2 76.8 93.3 83.2
Sec. & Higher 94.0 82.2 98.9 97.6 93.0 91.0 90.5 97.5 93.1
Wealth Status
Poor 88.7 20.5 97.3 89.3 87.9 61.2 87.1 91.0 86.9
Middle 91.9 30.3 98.8 92.6 89.9 69.4 93.7 93.9 90.3
Richest 93.2 57.8 98.7 95.8 90.8 89.0 90.3 97.8 93.4
Residential Areas
Rural 90.4 29.1 98.0 91.1 88.7 67.1 92.4 91.9 88.7
Urban 96.6 79.1 98.6 97.0 92.4 86.2 87.9 97.5 93.0
Media Exposure
Low 88.6 26.0 96.3 87.8 87.4 65.4 77.8 92.0 85.2
Moderate 93.5 48.5 98.2 93.0 90.6 76.5 91.2 94.3 90.3
High 96.0 75.2 99.4 96.0 92.5 93.4 91.1 97.3 95.6
Health Insurance Cover
No 90.5 34.1 92.3 89.2 71.8 89.8 93.7 89.3
Yes 92.4 63.1 97.0 92.3 89.8 84.1 97.9 97.6
Know MTCT
Low 25.5 12.9 87.1 74.1 63.5 56.4 60.9 54.9 46.6
Moderate 91.6 35.0 98.3 93.4 90.5 75.1 95.1 96.4 86.1
High 94.2 44.7 98.1 92.4 91.7 77.2 92.5 96.9 92.7
https://doi.org/10.1371/journal.pone.0242001.t002
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Table 3. Multivariable models showing factors associated with uptake of HIV testing in SSA.
Variables Uptake of HIV testing during pregnancy
UOR [95% CI] AOR [95% CI]
Age group in years
15–19 Ref Ref
20–24 1.31 [1.24,1.38]��� 1.21 [1.11,1.31]���
25–34 1.15 [1.09,1.21]��� 1.30 [1.20,1.41]���
35–49 1.07 [1.01,1.13]� 1.33 [1.21,1.46]���
Marital Status
Never Married Ref Ref
Currently married 0.42 [0.39,0.44]��� 0.98 [0.88,1.09]
Previously married 0.86 [0.78,0.94]�� 0.94 [0.82,1.07]
Cohabiting 0.79 [0.73,0.85]��� 1.08 [0.97,1.21]
Education level
None Ref Ref
Primary 5.67 [5.45,5.89]��� 1.60 [1.51,1.70]���
Secondary & Higher 8.84 [8.43,9.28]��� 2.57 [2.38,2.77]���
Wealth Status
Poor Ref Ref
Middle 1.37 [1.31,1.43]��� 1.37 [1.29,1.46]���
Rich 2.04 [1.97,2.11]��� 1.83 [1.70,1.97]���
Residence
Rural Ref Ref
Urban 1.69 [1.63,1.75]��� 1.68 [1.58,1.80]���
Media Exposure
Low Ref Ref
Moderate 2.12 [2.05,2.19]��� 1.43 [1.35,1.51]���
High 3.30 [3.14,3.48]��� 1.77 [1.62,1.94]���
Health Insurance Cover
No Ref Ref
Yes 3.96 [3.54,4.43]��� 1.41 [1.21,1.64]���
Knowledge of MTCT
Low Ref Ref
Moderate 19.46 [18.33,20.65]��� 5.92 [5.49,6.38]���
High 20.29 [19.32,21.32]��� 7.08 [6.66,7.53]���
Countries
Angola Ref Ref
Cameroon 3.47 [3.17,3.81]��� 2.84 [2.53,3.19]���
Chad 0.06 [0.06,0.07]��� 0.14 [0.12,0.17]���
Benin 0.29 [0.26,0.31]��� 0.40 [0.36,0.45]���
Guinea 0.30 [0.27,0.33]��� 0.32 [0.28,0.37]���
Mali 0.26 [0.24,0.28]��� 0.22 [0.20,0.25]���
Senegal 1.63 [1.50,1.77]��� 2.13 [1.90,2.39]���
Burundi 10.71 [9.60,11.94]��� 10.16 [8.92,11.58]���
Ethiopia 0.73 [0.67,0.80]��� 0.91 [0.81,1.03]
Rwanda 56.17 [43.18,73.05]��� 36.38 [27.74,47.71]���
Uganda 13.58 [12.13,15.19]��� 10.14 [8.92,11.54]���
Malawi 9.73 [8.82,10.73]��� 9.38 [8.28,10.62]���
Mozambique 3.44 [3.07,3.86]��� 4.15 [3.61,4.77]���
(Continued)
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of ANC in all countries, except in Benin, Burundi, Uganda, South Africa, Zambia, Zimbabwe,
Malawi, and Mozambique.
Discussion
We examined the coverage and factors associated with HIV testing among pregnant women in
SSA. Our study is timely, considering the global need for evidence to support the achievement
of the UNAIDS 95-95-95 targets [31]. Understanding the gaps in coverage of HIV testing dur-
ing pregnancy is critical for designing programmes to address the gaps and ensure even prog-
ress in SSA [2, 32]. Our analysis showed uneven progress in expanding access to HIV testing
during pregnancy in SSA. East and Southern African countries like Rwanda, Malawi, Zimba-
bwe and South Africa have expanded access to prenatal HIV testing for most women, irrespec-
tive of their education level, wealth status and place of residence. In contrast, prenatal care
HIV testing coverage was low in all West, and Central African countries studied. We also
found a higher uptake of HIV testing among women in Southern and Eastern African coun-
tries, compared to Western and Central African countries.
There are several pathways to understand these findings. First, the Southern and Eastern
African regions are most affected by HIV in the world (S7 Table) and are home to the largest
number of people living with HIV (20.6 million) [1]. In line with this, several countries in the
region such as Botswana, Kenya, Uganda, Malawi, and Rwanda have not only implemented
national campaigns to encourage uptake of HIV testing and counselling (HTC), they have also
implemented effective and efficient PMTCT, ensuring that most pregnant women are tested
for HIV and those diagnosed are placed on treatment [33–35]. They have deployed commu-
nity-based testing, which supports provider-initiated testing. Also, workplace and door-to-
door testing and self-testing, using rapid diagnostic tests, are being implemented in these sub-
regions [9].
Due to the heavy burden of HIV in the Eastern and Southern Africa regions, attention and
efforts of global developmental partners are concentrated on the region. Also, the governments
of countries in these regions, particularly South Africa, have invested heavily towards reducing
new HIV transmission and eliminating AIDS. The partnership of the local and global effort in
ending AIDS and preventing HIV transmission have no doubt bear tremendous results in East
and Southern Africa, including expanded access to HIV testing for pregnant women and
reduced MTCT of HIV. It is therefore imperative to focus more attention on West and Central
African countries to replicate the results recorded in East and Southern African in their
region.
Apart from these explanations, the high knowledge of MTCT and high HIV testing among
women in the Southern and Eastern African regions could also be linked to the high uptake of
Table 3. (Continued)
Variables Uptake of HIV testing during pregnancy
UOR [95% CI] AOR [95% CI]
South Africa 10.81 [8.89,13.15]��� 5.58 [4.47,6.97]���
Zambia 15.48 [13.46,17.81]��� 15.72 [13.36,18.48]���
Zimbabwe 11.07 [9.47,12.94]��� 5.88 [4.92,7.02]���
AOR is the adjusted odds ratio, UOR is the unadjusted odds ratio, ref is the reference; Exponentiated coefficients; 95% confidence intervals in brackets.
� p < 0.05
�� p < 0.01
��� p< 0.001.
https://doi.org/10.1371/journal.pone.0242001.t003
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antenatal care services (see S7 Table). Women in Central and West Africa were, on average,
less likely to receive antenatal care compared to women in Southern and Eastern Africa (see S7
Table). Nevertheless, despite the remarkable progress, particularly in South Africa, Rwanda,
and Uganda and Zimbabwe, no country has universal testing of pregnant women. As such,
programme implementers must make an effort to reach the missing pregnant women in the
HIV care cascade.
Also consistent with previous research [2, 34, 36] women who had secondary or higher edu-
cation, who owned health insurance and who resided in the wealthiest households were more
likely to be tested for HIV during pregnancy compared to those who did not have formal edu-
cation, did not have health insurance and lived in the poorest households. This finding was sig-
nificant in most countries studied, indicating socioeconomic gaps in ANC coverage of HIV
testing. Only a few countries in SSA (Rwanda, South Africa, Zimbabwe, Malawi and Zambia)
have managed to eliminate wealth and education inequality in access to HIV testing for preg-
nant women. These countries have demonstrated that eliminating inequalities in access to pre-
natal HIV testing is possible with the implementation of equitable policies. As such, other
countries in the region could draw lessons from these countries to provide universal access to
care and ensure that no one is left behind.
In most SSA countries studied, we observed rural-urban disparity in coverage of HIV test-
ing during pregnancy, highlighting the need to scale up prenatal HIV coverage in rural areas.
Rwanda, Zambia, Zimbabwe, Malawi, and Mozambique are the few countries where the rural
and urban disparity in coverage of prenatal HIV testing has been eliminated. Equitable access
to prenatal testing is vital for the health of women and babies in SSA. West and Central African
countries must address the rural and urban disparity in coverage of prenatal HIV testing to
save the lives of mothers and babies. Scaling up access to HIV testing in rural areas alone will
remarkably increase uptake in the West and Central Africa. Our findings on the association
between marital status and prenatal care uptake of HIV testing suggest no significant associa-
tion in 14 of the 16 countries studied. Married women were more likely to test for HIV in
Burundi but less likely to test in Zimbabwe. More studies are needed to understand this result.
The findings from this study have implications for policy and practice regarding the pre-
vention of MTCT in SSA. As shown in S7 Table, new HIV infections are high in Central and
West African countries, and these countries also have lower uptake of antenatal care, limiting
the level of prenatal HIV screening. Efforts to reduce or eliminate MTCT should focus on
West and Central Africa. Such efforts must target women who do not seek antenatal care ser-
vices. Our findings also underscore the need for PMTCT programmes to pay particular atten-
tion to knowledge on MTCT and socioeconomic inequality. Community-based interventions
delivered through women and church leaders could help improve women’s MTCT knowledge
in underserved settings, resulting in increased knowledge and uptake of HIV testing.
Strength and limitations
The strength of the study lies in the use of nationally representative survey data and the large
sample size. Notwithstanding, the study is without limitations. First, the use of the cross-sec-
tional study design, as employed in the DHS, limits the capacity of the authors to attribute cau-
sality to the findings. Again, the study adopted self-reporting of past events (prenatal care
uptake of HIV testing), which is subjected to social desirability and recall bias. The DHS, how-
ever, limits responses to this question to two years to reduce the impact of recall bias. Lastly,
there are several other unmeasured confounders such as couple testing, availability of testing
services and how testing is done, which could potentially influence the uptake of HIV testing
during ANC.
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Conclusion
The findings of the present study highlight the between countries and sub-regional disparities
in prenatal care uptake of HIV testing in SSA countries. Even though no country has a univer-
sal coverage of HIV testing of pregnant women, East and Southern African countries have
made remarkable progress towards ensuring no pregnant woman is not tested. However, the
coverage of testing is incredibly low in West and Central Africa, with the rich and well edu-
cated having better access to testing, while the poor are rarely tested. Addressing the inequita-
ble access and coverage of HIV testing among pregnant women is vital in these sub-regions. In
all countries studied, knowledge of MTCT was linked with a higher likelihood of testing,
which calls for appropriate interventions to increase awareness of MTCT. Such interventions
could be delivered through community leaders and mass media. In doing this, priority should
also be given to pregnant women in underserved settings, especially in West and Central
Africa.
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